Vulpe H, Kwan J Y Y, McNiven A, Brierley J D, Tsang R, Chan B, Goldstein D P, Le L W, Hope A, Giuliani M
Department of Radiation Oncology, Princess Margaret Cancer Centre.
Radiation Medicine Program, Princess Margaret Cancer Centre.
Curr Oncol. 2017 Jun;24(3):e226-e232. doi: 10.3747/co.24.3551. Epub 2017 Jun 27.
The radiotherapy (rt) volumes in anaplastic (atc) and differentiated thyroid carcinoma (dtc) are controversial.
We retrospectively examined the patterns of failure after postoperative intensity-modulated rt for atc and dtc. Computed tomography images were rigidly registered with the original rt plans. Recurrences were considered in-field if more than 95% of the recurrence volume received 95% of the prescribed dose, out-of-field if less than 20% received 95% of the dose, and marginal otherwise.
Of 30 dtc patients, 4 developed regional recurrence: 1 being in-field (level iii), and 3 being out-of-field (all level ii). Of 5 atc patients, all 5 recurred at 7 sites: 2 recurrences being local, and 5 being regional [2 marginal (intramuscular to the digastric and sternocleidomastoid), 3 out-of-field (retropharyngeal, soft tissues near the manubrium, and lateral to the sternocleidomastoid)].
In dtc, locoregional recurrence is unusual after rt. Out-of-field dtc recurrences infrequently occurred in level ii. Enlarged treatment volumes to level ii must be balanced against a potentially greater risk of toxicity.
间变性甲状腺癌(atc)和分化型甲状腺癌(dtc)的放疗(rt)靶区存在争议。
我们回顾性研究了atc和dtc术后调强放疗后的失败模式。计算机断层扫描图像与原始放疗计划进行刚性配准。如果复发体积的95%以上接受了95%的处方剂量,则复发被认为是野内复发;如果少于20%的复发体积接受了95%的剂量,则为野外复发;否则为边缘复发。
30例dtc患者中,4例出现区域复发:1例为野内复发(Ⅲ区),3例为野外复发(均为Ⅱ区)。5例atc患者中,5例均在7个部位复发:2例为局部复发,5例为区域复发[2例为边缘复发(二腹肌和胸锁乳突肌肌内),3例为野外复发(咽后、胸骨柄附近软组织和胸锁乳突肌外侧)]。
在dtc中,放疗后局部区域复发不常见。野外dtc复发很少发生在Ⅱ区。扩大至Ⅱ区的治疗靶区必须与潜在的更大毒性风险相权衡。